U
Neurobiological Technologies, Inc. NTII
$0.00 $0.000.00% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

12/17/2009 09/30/2009 06/30/2009 03/31/2009 12/31/2008
Total Cash And Short-Term Investments 13.62% -6.00% -19.78% -37.48% -55.84%
Total Receivables -- 1,530.43% -69.28% -61.90% -50.86%
Inventory -- -- -- -- --
Prepaid Expenses -- -23.51% 8.93% -61.79% 15.46%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets -- 3.71% -20.48% -38.06% -55.48%

Total Current Assets -- 3.71% -20.48% -38.06% -55.48%
Net Property, Plant & Equipment -- -89.60% -82.19% -76.02% -72.62%
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -- -38.82% -38.82% -70.69% -0.12%
Total Assets -- -24.29% -42.90% -38.72% -39.11%

Total Accounts Payable -- -- -96.43% -46.97% -50.24%
Total Accrued Expenses -- -86.90% -72.58% 78.68% 157.44%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -- -- -- -- --
Total Finance Division Other Current Liabilities -- -97.73% -94.68% 1.54% -5.80%
Total Other Current Liabilities -- -97.73% -94.68% 1.54% -5.80%
Total Current Liabilities -- -93.49% -87.67% 24.49% 43.97%

Total Current Liabilities -- -93.49% -87.67% 24.49% 43.97%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -39.53% -35.88%
Total Liabilities -- -97.04% -95.13% -14.52% -6.16%

Common Stock & APIC -- 0.34% 0.43% 0.62% 0.67%
Retained Earnings -- 8.80% 2.49% -11.86% -16.33%
Treasury Stock & Other -- 270.73% -- -11,033.33% -84,900.00%
Total Common Equity 258.18% 69.98% 16.26% -65.65% -70.75%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- 0.00% 0.00% 0.00% 0.00%
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity 0.00% 0.00% 0.00% 0.00% 0.00%

Total Common Equity 258.18% 69.98% 16.26% -65.65% -70.75%
Total Preferred Equity 0.00% 0.00% 0.00% 0.00% 0.00%
Total Minority Interest -- -- -- -- --
Total Equity 250.51% 68.98% 16.07% -64.94% -70.13%